Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines

PHASE4CompletedINTERVENTIONAL
Enrollment

1,043

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
MeaslesRubellaJapanese Encephalitis
Interventions
BIOLOGICAL

Measles-Rubella combined vaccine(MR)

0.5ml for each dose,be administered by single use syringe subcutaneously in the lower part of the deltoid area of lateral arm.

BIOLOGICAL

Japanese Encephalitis alive vaccine(JE)

0.5ml for each dose be administered by single use syringe subcutaneously in the lower part of the deltoid area of lateral arm.

Trial Locations (2)

Unknown

Hebei Provincial Center for Disease Control and Prevention, Shijiazhuang

Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Zhejiang Provincial Center for Disease Control and Prevention

OTHER_GOV

collaborator

Hubei Provincial Center for Disease Control and Prevention

OTHER

lead

Centers for Disease Control and Prevention, China

OTHER_GOV

NCT02643433 - Immunogenicity of Co-administration of Measles and Japanese Encephalitis Vaccines | Biotech Hunter | Biotech Hunter